Aukera Therapeutics' Biz Plan Competition Round

Aukera Therapeutics raised a round of funding on May 10, 2010. Investors include MIT $100K Entrepreneurship Competition.

Aukera Therapeutics is developing a novel therapeutic for the treatment of Amyotrophic Lateral Sclerosis (ALS) also known as Lou Gehrig's disease.…

Articles about Aukera Therapeutics' Biz Plan Competition Round: